# Memory Impairment Study (Mild Cognitive Impairment Study)

> **NCT00000173** · PHASE3 · COMPLETED · sponsor: **National Institute on Aging (NIA)**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Vitamin E

## Key facts

- **NCT ID:** NCT00000173
- **Lead sponsor:** National Institute on Aging (NIA)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 2004-01
- **Final completion:** 2004-01
- **Target enrollment:** — (—)
- **Last updated:** 2009-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000173, "Memory Impairment Study (Mild Cognitive Impairment Study)". Retrieved via MORVS 2026-11-06 from https://api.morvs.ai/clinical/NCT00000173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*